McKesson (MCK) Competitors

McKesson logo
$1,105.77 +2.96 (+0.27%)
Closing price 03:59 PM Eastern
Extended Trading
$1,104.73 -1.04 (-0.09%)
As of 05:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MCK vs. HQY, HSIC, MMSI, AMN, and BIO

Should you buy McKesson stock or one of its competitors? McKesson's main competitors and comparable companies include HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), and Bio-Rad Laboratories (BIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does McKesson compare to HealthEquity?

McKesson (NYSE:MCK) and HealthEquity (NASDAQ:HQY) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

McKesson has a beta of 0.27, suggesting that its stock price is 73% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market.

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson$403.43B0.32$4.76B$38.8928.37
HealthEquity$1.36B6.28$215.20M$2.7737.35

In the previous week, McKesson had 19 more articles in the media than HealthEquity. MarketBeat recorded 21 mentions for McKesson and 2 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.63 beat McKesson's score of 1.10 indicating that HealthEquity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
McKesson
15 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
HealthEquity
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

McKesson currently has a consensus price target of $1,040.29, indicating a potential downside of 5.71%. HealthEquity has a consensus price target of $113.53, indicating a potential upside of 9.74%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts plainly believe HealthEquity is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
McKesson
0 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.79
HealthEquity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.92

85.1% of McKesson shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 1.6% of HealthEquity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

HealthEquity has a net margin of 17.36% compared to McKesson's net margin of 1.12%. HealthEquity's return on equity of 15.33% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
McKesson1.12% -202.94% 5.92%
HealthEquity 17.36%15.33%9.51%

Summary

HealthEquity beats McKesson on 11 of the 17 factors compared between the two stocks.

How does McKesson compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and McKesson (NYSE:MCK) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.

McKesson has higher revenue and earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Henry Schein$13.18B0.72$398M$3.6523.62
McKesson$403.43B0.32$4.76B$38.8928.37

Henry Schein has a net margin of 3.07% compared to McKesson's net margin of 1.12%. Henry Schein's return on equity of 16.39% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Henry Schein3.07% 16.39% 5.58%
McKesson 1.12%-202.94%5.92%

Henry Schein has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market. Comparatively, McKesson has a beta of 0.27, meaning that its stock price is 73% less volatile than the broader market.

In the previous week, McKesson had 20 more articles in the media than Henry Schein. MarketBeat recorded 21 mentions for McKesson and 1 mentions for Henry Schein. McKesson's average media sentiment score of 1.10 beat Henry Schein's score of 0.89 indicating that McKesson is being referred to more favorably in the news media.

Company Overall Sentiment
Henry Schein Positive
McKesson Positive

Henry Schein currently has a consensus target price of $93.57, suggesting a potential upside of 8.53%. McKesson has a consensus target price of $1,040.29, suggesting a potential downside of 5.71%. Given Henry Schein's higher probable upside, equities analysts clearly believe Henry Schein is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Henry Schein
1 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.50
McKesson
0 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.79

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

McKesson beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and McKesson (NYSE:MCK) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

McKesson has higher revenue and earnings than Merit Medical Systems. McKesson is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.52B3.42$128.49M$2.6632.57
McKesson$403.43B0.32$4.76B$38.8928.37

In the previous week, McKesson had 18 more articles in the media than Merit Medical Systems. MarketBeat recorded 21 mentions for McKesson and 3 mentions for Merit Medical Systems. McKesson's average media sentiment score of 1.10 beat Merit Medical Systems' score of 0.96 indicating that McKesson is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
McKesson
15 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market. Comparatively, McKesson has a beta of 0.27, indicating that its stock price is 73% less volatile than the broader market.

Merit Medical Systems presently has a consensus price target of $105.55, indicating a potential upside of 21.83%. McKesson has a consensus price target of $1,040.29, indicating a potential downside of 5.71%. Given Merit Medical Systems' higher possible upside, equities analysts plainly believe Merit Medical Systems is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.62
McKesson
0 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.79

Merit Medical Systems has a net margin of 9.94% compared to McKesson's net margin of 1.12%. Merit Medical Systems' return on equity of 14.12% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.94% 14.12% 8.37%
McKesson 1.12%-202.94%5.92%

Summary

Merit Medical Systems and McKesson tied by winning 8 of the 16 factors compared between the two stocks.

How does McKesson compare to AMN Healthcare Services?

McKesson (NYSE:MCK) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

85.1% of McKesson shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

McKesson has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson$403.43B0.32$4.76B$38.8928.37
AMN Healthcare Services$2.73B0.54-$95.70M$2.7513.84

In the previous week, McKesson had 13 more articles in the media than AMN Healthcare Services. MarketBeat recorded 21 mentions for McKesson and 8 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.10 beat AMN Healthcare Services' score of 0.47 indicating that McKesson is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
McKesson
15 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

McKesson has a beta of 0.27, suggesting that its share price is 73% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market.

McKesson currently has a consensus target price of $1,040.29, suggesting a potential downside of 5.71%. AMN Healthcare Services has a consensus target price of $39.17, suggesting a potential upside of 2.94%. Given AMN Healthcare Services' higher probable upside, analysts clearly believe AMN Healthcare Services is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
McKesson
0 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.79
AMN Healthcare Services
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33

AMN Healthcare Services has a net margin of 3.10% compared to McKesson's net margin of 1.12%. AMN Healthcare Services' return on equity of 23.42% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
McKesson1.12% -202.94% 5.92%
AMN Healthcare Services 3.10%23.42%7.19%

Summary

McKesson and AMN Healthcare Services tied by winning 8 of the 16 factors compared between the two stocks.

How does McKesson compare to Bio-Rad Laboratories?

Bio-Rad Laboratories (NYSE:BIO) and McKesson (NYSE:MCK) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

McKesson has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad Laboratories$2.58B3.82$759.90M$37.979.65
McKesson$403.43B0.32$4.76B$38.8928.37

65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 30.3% of Bio-Rad Laboratories shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Bio-Rad Laboratories currently has a consensus price target of $366.67, indicating a potential upside of 0.02%. McKesson has a consensus price target of $1,040.29, indicating a potential downside of 5.71%. Given Bio-Rad Laboratories' higher probable upside, equities analysts clearly believe Bio-Rad Laboratories is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Rad Laboratories
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20
McKesson
0 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.79

Bio-Rad Laboratories has a net margin of 39.45% compared to McKesson's net margin of 1.12%. Bio-Rad Laboratories' return on equity of 3.58% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Rad Laboratories39.45% 3.58% 2.51%
McKesson 1.12%-202.94%5.92%

In the previous week, McKesson had 9 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 21 mentions for McKesson and 12 mentions for Bio-Rad Laboratories. McKesson's average media sentiment score of 1.10 beat Bio-Rad Laboratories' score of 0.10 indicating that McKesson is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bio-Rad Laboratories
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
McKesson
15 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Bio-Rad Laboratories has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market. Comparatively, McKesson has a beta of 0.27, suggesting that its stock price is 73% less volatile than the broader market.

Summary

McKesson beats Bio-Rad Laboratories on 10 of the 16 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Sign up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MCK vs. The Competition

MetricMcKessonHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$127.67B$10.88B$7.83B$23.17B
Dividend Yield0.34%2.54%2.47%3.79%
P/E Ratio28.4336.4034.3429.41
Price / Sales0.322.018.003.27
Price / Cash24.2023.2821.0215.64
Price / Book-76.213.984.764.04
Net Income$4.76B$332.46M$3.52B$1.07B
7 Day Performance4.37%-3.42%-5.34%-3.09%
1 Month Performance9.98%-0.46%-3.61%-1.21%
1 Year Performance31.29%21.03%0.01%5.63%

McKesson Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MCK
McKesson
4.1713 of 5 stars
$1,105.77
+0.3%
$1,040.29
-5.9%
+31.0%$127.67B$403.43B28.4343,000
HQY
HealthEquity
3.6099 of 5 stars
$102.11
-1.5%
$113.53
+11.2%
+1.7%$9.00B$1.31B36.862,814
HSIC
Henry Schein
2.3184 of 5 stars
$88.41
+2.7%
$93.57
+5.8%
+20.7%$9.75B$13.18B24.2225,000
MMSI
Merit Medical Systems
3.7518 of 5 stars
$88.42
+1.4%
$105.55
+19.4%
+1.8%$5.43B$1.52B23.307,500
AMN
AMN Healthcare Services
1.9897 of 5 stars
$38.00
+5.0%
$39.17
+3.1%
+140.4%$1.85B$2.73B13.722,664

Related Companies and Tools


This page (NYSE:MCK) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners